Emily Anderson, MS

Emily Anderson, MS is the regulatory policy lead for the Physicians Committee for Responsible Medicine, a nationwide organization of physicians and laypersons that promotes preventative medicine, conducts clinical research, and advocates for ethical and effective medical research, product testing, and training.

At the Physicians Committee, Emily manages federal lobbying efforts to promote the development, use, and implementation of human-specific, nonanimal research and testing methods that are more relevant to humans and help reduce and replace animal experiments. Since 2017, Emily has led successful efforts that contributed to increased federal funding for nonanimal methods, and congressional directives to help agencies transition away from animal use and better integrate human-specific approaches.

With the help of her team, Emily develops effective strategies to overcome the many barriers to use of human-specific methods. To garner support for the Physicians Committee’s legislative and policy proposals, Emily builds and maintains relationships with legislators, and frequently meets with congressional offices to discuss the scientific and ethical advantages of nonanimal approaches.

Emily organizes and hosts events on Capitol Hill, including congressional briefings and a Lobby Day, to demonstrate the importance of prioritizing innovative nonanimal approaches in federal laws and policies. She consistently monitors legislation, hearings, and other activities for opportunities to further push for modernized research and testing policies, and effectively engages with congressional staff, agency staff, industry representatives, non-governmental organizations, and Physicians Committee members.

Emily earned her master’s degree in animals and public policy from Tufts University, and her bachelor’s degree in biology from Smith College. She is a member of the American Society for Cellular and Computational Toxicology and the Women in Government Relations Association.